key: cord-0813293-lh9v8uhz
authors: Ambade, Vivek
title: Biochemical rationale for hypoalbuminemia in COVID‐19 patients
date: 2020-10-05
journal: J Med Virol
DOI: 10.1002/jmv.26542
sha: be2a05f457e435827ccfe0045cdc4ab87fa79559
doc_id: 813293
cord_uid: lh9v8uhz

Recently, Huang J et al 1 have published an article in this journal, wherein they concluded that hypoalbuminemia is associated with the outcome of COVID-19. This article is protected by copyright. All rights reserved.

To the Editor, Recently, Huang et al. 1 have published an article in this journal, wherein they concluded that hypoalbuminemia is associated with the outcome of coronavirus disease . However, the mechanism for hypoalbuminemia in COVID-19 has not been explained.

Considering the median onset time (time from the onset of illness to admission) of 3 In fact, hypoalbuminemia appears due to increased catabolism to make the AAs available, with simultaneously decreased

Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity

The bioenergetic costs of a gene

Metabolic efficiency and amino acid composition in the proteomes of Escherichia coli and Bacillus subtilis

A structural analysis of M protein in coronavirus assembly and morphology

Virological assessment of hospitalized patients with COVID-2019

Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans

Potential role of amino acid/protein nutrition and exercise in serum albumin redox state

Role of human albumin in the management of complications of liver cirrhosis

Tests of the functions of the Liver

T A B L E 1 Distribution of amino acids in structural proteins of SARS-CoV-2, energy expenditure in terms of number of ATPs to synthesize viral RNA, viral proteins, and burden of eight essential amino acids on human body in generating virus Abbreviations: E, envelope protein; EAA, essential amino acid; M, membrane protein; N, nucleocapsid protein; NA, not applicable; NEAA, nonessential amino acid; NT, nucleotide; S, spike protein; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2. a Burden of EAA on the human host is calculated in terms of number of EAAs stript per virus particle.